Made available in DSpace on 2014-06-11T19:27:23Z (GMT). No. of bitstreams: 0 Previous issue date: 2010-06-25Bitstream added on 2014-06-13T20:56:24Z : No. of bitstreams: 1 caliman_mcw_me_jabo.pdf: 1793732 bytes, checksum: 2e6b8864381cb4eeeb7aba6bc8d4c882 (MD5) / A resistência antimicrobiana em bactérias de origem animal tem se caracterizado como importante problema de saúde pública. No Brasil, muitos trabalhos têm verificado a presença de fatores de virulência e resistência em cepas de Escherichia coli isoladas de animais de produção, porém há poucos estudos avaliando estes aspectos em animais de companhia. O presente trabalho verificou o perfil de sensibilidade microbiana e a presença dos genes codificadores de adesinas (pap, sfa, afa), de intimina (eae) e de Shiga toxina (stx1, stx2) em cepas fecais de E. coli obtidas através de swabs retais de gatos diarréicos e de saudáveis, e em cepas urinárias de gatos com sintomas de infecção do trato urinário (ITU) apresentados para consultas e vacinação em clínicas veterinárias da região de Ribeirão Preto. Entre Janeiro e dezembro de 2009 foram isoladas 205 cepas de E. coli que foram caracterizadas quanto à presença de genes codificadores de fatores de virulência por PCR e sensibilidade microbiana pelo método de difusão em discos. O gene sfa ocorreu em maior abundância (35,6%) sendo mais freqüente entre animais com diarréia e ITU que entre os saudáveis. O gene eae foi verificado apenas entre os diarréicos (2,4%) e sempre associado ao sfa. O gene pap ocorreu em todos os grupos (22,43%). Genes stx1,stx2 e afa não foram encontrados. As resistências predominantemente observadas foram para cefalotina (42,1%), tetraciclina (20%) e ampicilina (15,8%) entre os isolados dos gatos diarréicos enquanto nos dos saudáveis as resistências mais freqüentes foram tetraciclina (30,5%), cotrimoxazol (17,9%) e ampicilina (20,0%). Gatos com ITU apresentaram maiores resistências para ampicilina (46,7%), cefalotina (13,3%) e ácido nalidíxico (13,3%). Multiresistência foi encontrada... / Antimicrobial resistance in animal origin bacteria has been characterized as an important public health problem. In Brazil, many studies have verified the presence of antimicrobial virulence factors and resistance in strains of Escherichia coli isolated from livestock, however there are few studies evaluating these aspects in pets. The current work verified the sensibility profile and the presence of genes encoding adhesins (pap, sfa, afa) intimin (eae) and Shiga toxin (stx1, stx2) in E. coli fecal strains obtained from rectal swabs from diarrheic and healthy cats and urinary strains from cats with symptoms of urinary tract infection (UTI) presented to be consulted and get vaccination in veterinary clinics in the region of Ribeirão Preto. Between January and December 2009 were isolated 205 strains of E. coli that have been characterized for the presence of genes encoding virulence factors by PCR and microbial sensitibility by disc diffusion method. The sfa gene occurred in greatest abundance (35.6%) was more common among animals with diarrhea and UTI than among the healthy. The eae gene was found only among diarrheic (2.4%) and always associated with sfa. The pap gene occurred in all groups (22.43%). Genes stx1, stx2 and afa were not found. The predominantly observed resistance was to cephalothin (42.1%), tetracycline (20%) and ampicillin (15.8%) among the isolates from diarrheic cats while in the healthy the tetracycline resistance was most frequent (30.5%), allowed by cotrimoxazol (17.9%) and ampicillin (20.0%). Cats with UTI showed greater resistance to ampicillin (46.7%), cephalothin (13.3%) and nalidixic acid (13.3%). Multidrug resistance was found in 8.4%, 17.9% and 33.3% of strains isolated from diarrheic healthy and with symptoms of UTI cats, respectively. The phenotype of resistance extended to beta-lactams (ESBL) was not... (Summary complete electronic access click below)

This dissertation describes the synthesis, antimicrobial properties, and catalytic activity of a variety of eta5-ligand rhodium and iridium complexes. Cp*RM(beta-diketonato)Cl (Cp*R = R-substituted tetramethylcyclopentadienyl ligand) complexes were found to have selective activity against Mycobacterium smegmatis, with activity highly dependent upon the substituents on the Cp*R ligand as well as on the beta-diketonato ligand. These complexes were synthesized in good yield from the reaction of the chloro bridged dimers ([Cp*RMCl2]2) with the desired beta-diketonato ligand under basic conditions. All complexes were fully characterized by 1H and 13C NMR. Twenty single crystal X-ray structures were solved. The success of these syntheses led to investigation of another beta-diketonato ligand: 1,1,1,5,5,5-hexafluoroacetylacetonate (hfac). Though many metal complexes of this ligand are known, reaction with [Cp*MCl2]2 did not yield the desired Cp*M(hfac)Cl complexes. Instead, a variety of products were obtained, three of which were characterized crystallographically. The most interesting structure featured a non-coordinating trifluoroacetate (TFA) anion and a [Cp*Ir]3Na1O4 cubane structure, which is an unprecedented and highly unusual arrangement for iridium. Attempts to synthesize this cluster rationally through reactions of [Cp*IrCl2]2 with TFA yielded instead a chloro bridged [Cp*IrCl(TFA)] dimer. Reaction of [Cp*MCl2]2 with 1,1,1-trifluoroacetylacetonate (tfac) yielded the expected Cp*M(tfac)Cl complex, indicating that the problem lies with using hfac as a ligand for Cp*M(III) complexes. Finally, the indenyl effect was investigated for the oxidative annulation of 2-phenylimidazole with 1-phenyl-1-propyne catalyzed by a series of methyl-substituted [(indenyl)RhCl2] dimers. [(Ind*)RhCl2]2 was found to have significantly greater activity than [Cp*RhCl2]2 (100% vs. 51%). Two plausible catalytic cycles were proposed, one of which invokes a ring slip transition state. Though it is unclear if the "indenyl effect" is responsible for this differing activity, it is certainly apparent that using an indenyl ligand has a notable effect in this catalytic reaction. Cyclometalation was also investigated stoichiometrically for 2-phenyl-1H-imidazole and 1-phenylpyrazole and found to proceed readily for [(Ind*)RhCl2]2. Additionally, the crystallographic structure of a Rh+ /Rh– ionic pair was solved. Ionic pairs such as this are rarely found in the literature. / Doctor of Philosophy / This dissertation deals with the uses of a series of unusual compounds containing the metals rhodium and iridium. Though these are rare and expensive metals, the uses and benefits described in this dissertation far outweigh the costs. Overall, the compounds described in this dissertation are colorfully characterized as “piano stool” compounds because of their overall shape and appearance. The metal, either rhodium or iridium, occupies a central point in the complex. On top of the metal is a “flat” organic group that gives the appearance of the seat of the piano stool. Below the metal, there are three other groups that look like the legs of the piano stool. By appropriate choice of the metals and the surrounding groups, special properties can be designed into these “piano stool” complexes. Chapter 2 describes the synthesis of a series of complexes where the “flat” group is a variant of a five-membered carbon ring compound known as cyclopentadienyl, the metal is rhodium or iridium, and two of the three legs come from a family of compounds known as acetylacetonates (acac). This series of piano stool compounds display antimicrobial activity against a class of pathogens known as mycobacteria, an example of which causes the disease tuberculosis. Changing the cyclopentadienyl group and the acac group allows for this antimicrobial activity to be tuned. In the following chapter, attempts to make the same type of compound described in the paragraph above with fluorine-substituted acacs gave some very unexpected results. The most surprising result was a very unusual cube-shaped structure containing 3 iridium atoms, 1 sodium atom, and 4 oxygen atoms, which is an unprecedented arrangement for iridium. Finally, there is a specific example of a flat group for the piano stool known as indenyl. Indenyl is intriguing because it can change shape from a flat group to a bent group. In doing this, it provides more space around the metal for other molecules to bind. The result of this work shows that piano stool compounds created with this indenyl group are more active and selective for carrying out a catalytic reaction to make new ring systems that could have potential use in the synthesis of new flavorings, fragrances, and even pharmaceuticals.

O objetivo deste trabalho foi avaliar o potencial antifúngico contra o fungo Aspergillus flavus, dos extratos de folhas de Eucalyptus staigeriana F. Muell., preparados a partir de folhas frescas, liofilizadas e secas ao ambiente, sob diferentes tempos de extração e por diferentes solventes extratores, tais como metanol, etanol e água a temperatura ambiente e água a 60ºC. Para mensurar o potencial antifúngico foi utilizada a técnica de poisoned food em meio BDA e o crescimento radial fúngico foi avaliado por seis dias. O percentual de inibição foi avaliado comparando-se as medidas do diâmetro radial de crescimento fúngico dos extratos com as placas controle contendo apenas os solventes. Como controle positivo foi utilizado o óleo essencial de E. staigeriana. Os extratos metanólicos apresentaram o melhor potencial antifúngico, seguido pelos extratos etanólicos e aquosos. A utilização das folhas frescas mostrou-se a melhor forma de preparação e não houve diferença significativa entre os tempos de extração 1h e 24h, indicando como processamento mais viável a extração em 1h. A Concentração Inibitória Mínima (MIC) foi mensurada para o extrato de melhor desempenho pela técnica de micropoços, aonde o crescimento fúngico foi monitorado por fluorescência derivada da reação da esterase fúngica com o diacetado de fluorescina. E o extrato que obteve o melhor resultado foi o extrato metanólico, com 1h de extração, a partir de folhas liofilizadas de E. staigeriana, e sua MIC foi de 26,75 L/mL, enquanto a do seu óleo essencial foi de 12,5 L/mL, demonstrando a eficiência relativa da extração com solventes extratores e sua praticidade e operacionalidade, quando se comparam com a extração de óleos essenciais. / This study aimed to evaluate the antifungal potential of Eucalyptus staigeriana F. Muell. leaf extracts against Aspergillus flavus. The extracts were prepared using fresh, lyophilized, and air-dried leaves, different extraction times, and different solvents, such as methanol, ethanol, water at room temperature, and water at 60ºC. To measure the antifungal potential, the poisoned food technique was used in PDA medium, and the radial growth of the fungus was evaluated for six days. The percentage of inhibition was assessed by comparing the measurements of the radial growth diameter of the fungus in the extracts with the control plates containing only the solvents. The essential oil of E. staigeriana was used as a positive control. The methanolic extracts presented the best antifungal potential, followed by the ethanolic and aqueous extracts. The use of fresh leaves was the best type of preparation and no statistically significant difference between 1-h and 24-h solvent extraction was found, indicating the 1-h extraction process as the most feasible. The extract presenting the best performance using the microwell technique had the minimum inhibitory concentration (MIC) measured, and the fungal growth was monitored by fluorescence derived from the fungal esterase reaction with fluorescein diacetate. The extract that achieved the best result the methanolic extract, with 1-h extraction from lyophilized leaves of E. staigeriana, and the MIC was 26.75 L/mL, while the essential oil was 12.5 L/mL, demonstrating the relative efficiency of the solvent extraction and its practicality and easy implementation when compared with the extraction of essential oils.

O uso de agentes químicos coadjuvantes da higienização bucal pode ser necessário para o controle da microbiota cariogênica de indivíduos com alto risco e atividade da doença cárie. Atualmente o agente antimicrobiano mais recomendado é o digluconato de clorexidina (CHX) devido ao seu amplo espectro de ação e efeito residual. Contudo, quando utilizado por longos períodos, este agente químico apresenta efeitos colaterais. Neste contexto, os polifenóis naturais, como a Epigalocatequina3galato (EGCG), derivada do chá verde, vêm sendo propostos como alternativa aos agentes antimicrobianos sintéticos. Entretanto, os polifenóis não apresentam estabilidade ao longo do tempo, podendo se oxidar rapidamente. Desta forma, o encapsulamento da EGCG em nanopartículas poderia aumentar a sua biodisponibilidade e estabilidade física e química, manter o efeito deste polifenol no tecido alvo e potencializar sua eficácia farmacológica. Assim, o presente estudo teve como objetivo desenvolver e caracterizar sistemas de encapsulamento de EGCG e avaliar, in vitro, sua atividade antimicrobiana frente a microorganismos cariogênicos. Inicialmente, foram preparadas nanopartículas poliméricas (NPP) e carreadores lipídicos nanoestruturados (CLN), que foram caracterizados e avaliados quanto à sua atividade antimicrobiana in vitro frente aos microorganismos Streptococcus mutans, Streptococcus sobrinus e Lactobacillus casei. Após a análise dos resultados microbiológicos, o CLN foi selecionado para o encapsulamento da EGCG (CLNEGCG), por apresentar atividade antimicrobiana frente à todos os microorganismos avaliados. O CLNEGCG foi preparado pelo método de emulsão e sonicação e caracterizado quanto ao diâmetro, índice de polidispersão (PdI), potencial zeta (PZ), eficiência de encapsulamento (EE), cristalinidade, capacidade de mucoadesão e morfologia. A atividade antimicrobiana in vitro da EGCG livre e encapsulada foi avaliada por meio da determinação da concentração inibitória mínima (CIM) e concentração bactericida mínima (CBM). O diâmetro, PdI e o PZ dos CLN foram 228nm, 0,216 e 36,53mV, respectivamente, sendo que o encapsulamento da EGCG não alterou significativamente estes parâmetros. O CLN apresentou forma esférica, estabilidade por 330 dias e propriedade mucoadesiva devido a presença de quitosana na superfície do CLN. Além disso, a quitosana favoreceu o encapsulamento da EGCG obtendose uma EE de ~96%. As concentrações inibitórias e bactericidas mínimas do CLNEGCG (33,75 a 67,5 µg/mL) foram menores do que as verificadas para a EGCG livre (250 a 2.000 µg/mL), comprovando o aumento do potencial antimicrobiano com o encapsulamento da EGCG em nanocarreadores híbridos. De acordo com esses resultados, o CLNEGCG, desenvolvido no presente trabalho, constitui um sistema com potencial para o uso tópico bucal, pois além de ser estável e apresentar propriedade de mucoadesão e morfologia adequada, apresentaram alta atividade antimicrobiana frente aos principais microorganismos envolvidos no processo carioso. / The use of oral hygiene adjuvants may be necessary to control the cariogenic microbiota of individuals with high risk and caries disease activity. Currently the most recommended antimicrobial agent is chlorhexidine digluconate (CHX) because of its broad spectrum of action and residual effect. However, this chemical has side effects. In this context, as an Epigallocatechin3gallate (EGCG), a derivative of green tea, as an alternative to synthetic antimicrobial agents. However, there is no stability over time and can oxidize rapidly. Thus, the encapsulation of EGCG in nanoparticles can increase their bioavailability and physical and chemical stability, maintain the effect of this polyphenol on the target tissue and potentiate its pharmacological efficacy. Thus, the present study aimed to develop and characterize EGCG encapsulation systems and to evaluate, in vitro, its antimicrobial activity against cariogenic microorganisms. Initially, polymer nanoparticles (NPP) and nanostructured lipid carriers (CLN) were prepared and evaluated for their in vitro antimicrobial activity against Streptococcus mutans, Streptococcus sobrinus and Lactobacillus casei microorganisms. After the analysis of the microbiological results, the CLN was selected for the encapsulation of EGCG (CLNEGCG), due to its higher antimicrobial activity. The CLNEGCG was developed by emulsion and sonication method and was characterized in relation to diameter, polydispersity index (PdI), zeta potential (PZ), encapsulation efficiency (EE), crystallinity, mucoadhesion capacity and morphology. The in vitro antimicrobial activity of EGCG and its ability to evaluate minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). The diameter, PdI and PZ of the CLNs were 228nm, 0.216 and 36.53mV, respectively, and the EGCG encapsulation did not significantly alter these parameters. The CLN showed a spherical structure, stability for 330 days and a mucoadhesive property due to a presence of chitosan on the CLN surface. In addition, a chitosan favored EGCG encapsulation resulting in an EE of ~ 96%. The minimum inhibitory and bactericidal concentrations of CLGEGCG (33.75 to 67.5 µg / mL) were lower than those for free EGCG (250 to 2,000 µg / mL), with increased antimicrobial potential with EGCG encapsulation in hybrid nanocarriers. According to the results, the CLNEGCG, developed in the present study, constitutes a system with potential for oral topical use, besides being stable and possessing mucoadhesion properties, presented high antimicrobial activity against the main microorganisms involved in the carious process.

O uso de agentes químicos coadjuvantes da higienização bucal pode ser necessário para o controle da microbiota cariogênica de indivíduos com alto risco e atividade da doença cárie. Atualmente o agente antimicrobiano mais recomendado é o digluconato de clorexidina (CHX) devido ao seu amplo espectro de ação e efeito residual. Contudo, quando utilizado por longos períodos, este agente químico apresenta efeitos colaterais. Neste contexto, os polifenóis naturais, como a Epigalocatequina3galato (EGCG), derivada do chá verde, vêm sendo propostos como alternativa aos agentes antimicrobianos sintéticos. Entretanto, os polifenóis não apresentam estabilidade ao longo do tempo, podendo se oxidar rapidamente. Desta forma, o encapsulamento da EGCG em nanopartículas poderia aumentar a sua biodisponibilidade e estabilidade física e química, manter o efeito deste polifenol no tecido alvo e potencializar sua eficácia farmacológica. Assim, o presente estudo teve como objetivo desenvolver e caracterizar sistemas de encapsulamento de EGCG e avaliar, in vitro, sua atividade antimicrobiana frente a microorganismos cariogênicos. Inicialmente, foram preparadas nanopartículas poliméricas (NPP) e carreadores lipídicos nanoestruturados (CLN), que foram caracterizados e avaliados quanto à sua atividade antimicrobiana in vitro frente aos microorganismos Streptococcus mutans, Streptococcus sobrinus e Lactobacillus casei. Após a análise dos resultados microbiológicos, o CLN foi selecionado para o encapsulamento da EGCG (CLNEGCG), por apresentar atividade antimicrobiana frente à todos os microorganismos avaliados. O CLNEGCG foi preparado pelo método de emulsão e sonicação e caracterizado quanto ao diâmetro, índice de polidispersão (PdI), potencial zeta (PZ), eficiência de encapsulamento (EE), cristalinidade, capacidade de mucoadesão e morfologia. A atividade antimicrobiana in vitro da EGCG livre e encapsulada foi avaliada por meio da determinação da concentração inibitória mínima (CIM) e concentração bactericida mínima (CBM). O diâmetro, PdI e o PZ dos CLN foram 228nm, 0,216 e 36,53mV, respectivamente, sendo que o encapsulamento da EGCG não alterou significativamente estes parâmetros. O CLN apresentou forma esférica, estabilidade por 330 dias e propriedade mucoadesiva devido a presença de quitosana na superfície do CLN. Além disso, a quitosana favoreceu o encapsulamento da EGCG obtendose uma EE de ~96%. As concentrações inibitórias e bactericidas mínimas do CLNEGCG (33,75 a 67,5 µg/mL) foram menores do que as verificadas para a EGCG livre (250 a 2.000 µg/mL), comprovando o aumento do potencial antimicrobiano com o encapsulamento da EGCG em nanocarreadores híbridos. De acordo com esses resultados, o CLNEGCG, desenvolvido no presente trabalho, constitui um sistema com potencial para o uso tópico bucal, pois além de ser estável e apresentar propriedade de mucoadesão e morfologia adequada, apresentaram alta atividade antimicrobiana frente aos principais microorganismos envolvidos no processo carioso. / The use of oral hygiene adjuvants may be necessary to control the cariogenic microbiota of individuals with high risk and caries disease activity. Currently the most recommended antimicrobial agent is chlorhexidine digluconate (CHX) because of its broad spectrum of action and residual effect. However, this chemical has side effects. In this context, as an Epigallocatechin3gallate (EGCG), a derivative of green tea, as an alternative to synthetic antimicrobial agents. However, there is no stability over time and can oxidize rapidly. Thus, the encapsulation of EGCG in nanoparticles can increase their bioavailability and physical and chemical stability, maintain the effect of this polyphenol on the target tissue and potentiate its pharmacological efficacy. Thus, the present study aimed to develop and characterize EGCG encapsulation systems and to evaluate, in vitro, its antimicrobial activity against cariogenic microorganisms. Initially, polymer nanoparticles (NPP) and nanostructured lipid carriers (CLN) were prepared and evaluated for their in vitro antimicrobial activity against Streptococcus mutans, Streptococcus sobrinus and Lactobacillus casei microorganisms. After the analysis of the microbiological results, the CLN was selected for the encapsulation of EGCG (CLNEGCG), due to its higher antimicrobial activity. The CLNEGCG was developed by emulsion and sonication method and was characterized in relation to diameter, polydispersity index (PdI), zeta potential (PZ), encapsulation efficiency (EE), crystallinity, mucoadhesion capacity and morphology. The in vitro antimicrobial activity of EGCG and its ability to evaluate minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). The diameter, PdI and PZ of the CLNs were 228nm, 0.216 and 36.53mV, respectively, and the EGCG encapsulation did not significantly alter these parameters. The CLN showed a spherical structure, stability for 330 days and a mucoadhesive property due to a presence of chitosan on the CLN surface. In addition, a chitosan favored EGCG encapsulation resulting in an EE of ~ 96%. The minimum inhibitory and bactericidal concentrations of CLGEGCG (33.75 to 67.5 µg / mL) were lower than those for free EGCG (250 to 2,000 µg / mL), with increased antimicrobial potential with EGCG encapsulation in hybrid nanocarriers. According to the results, the CLNEGCG, developed in the present study, constitutes a system with potential for oral topical use, besides being stable and possessing mucoadhesion properties, presented high antimicrobial activity against the main microorganisms involved in the carious process.

Orientador: José Moacir Marin / Banca: Maria de Fátima Martins / Banca: Tammy Priscilla Chioda Delfino / Resumo: A resistência antimicrobiana em bactérias de origem animal tem se caracterizado como importante problema de saúde pública. No Brasil, muitos trabalhos têm verificado a presença de fatores de virulência e resistência em cepas de Escherichia coli isoladas de animais de produção, porém há poucos estudos avaliando estes aspectos em animais de companhia. O presente trabalho verificou o perfil de sensibilidade microbiana e a presença dos genes codificadores de adesinas (pap, sfa, afa), de intimina (eae) e de Shiga toxina (stx1, stx2) em cepas fecais de E. coli obtidas através de swabs retais de gatos diarréicos e de saudáveis, e em cepas urinárias de gatos com sintomas de infecção do trato urinário (ITU) apresentados para consultas e vacinação em clínicas veterinárias da região de Ribeirão Preto. Entre Janeiro e dezembro de 2009 foram isoladas 205 cepas de E. coli que foram caracterizadas quanto à presença de genes codificadores de fatores de virulência por PCR e sensibilidade microbiana pelo método de difusão em discos. O gene sfa ocorreu em maior abundância (35,6%) sendo mais freqüente entre animais com diarréia e ITU que entre os saudáveis. O gene eae foi verificado apenas entre os diarréicos (2,4%) e sempre associado ao sfa. O gene pap ocorreu em todos os grupos (22,43%). Genes stx1,stx2 e afa não foram encontrados. As resistências predominantemente observadas foram para cefalotina (42,1%), tetraciclina (20%) e ampicilina (15,8%) entre os isolados dos gatos diarréicos enquanto nos dos saudáveis as resistências mais freqüentes foram tetraciclina (30,5%), cotrimoxazol (17,9%) e ampicilina (20,0%). Gatos com ITU apresentaram maiores resistências para ampicilina (46,7%), cefalotina (13,3%) e ácido nalidíxico (13,3%). Multiresistência foi encontrada... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Antimicrobial resistance in animal origin bacteria has been characterized as an important public health problem. In Brazil, many studies have verified the presence of antimicrobial virulence factors and resistance in strains of Escherichia coli isolated from livestock, however there are few studies evaluating these aspects in pets. The current work verified the sensibility profile and the presence of genes encoding adhesins (pap, sfa, afa) intimin (eae) and Shiga toxin (stx1, stx2) in E. coli fecal strains obtained from rectal swabs from diarrheic and healthy cats and urinary strains from cats with symptoms of urinary tract infection (UTI) presented to be consulted and get vaccination in veterinary clinics in the region of Ribeirão Preto. Between January and December 2009 were isolated 205 strains of E. coli that have been characterized for the presence of genes encoding virulence factors by PCR and microbial sensitibility by disc diffusion method. The sfa gene occurred in greatest abundance (35.6%) was more common among animals with diarrhea and UTI than among the healthy. The eae gene was found only among diarrheic (2.4%) and always associated with sfa. The pap gene occurred in all groups (22.43%). Genes stx1, stx2 and afa were not found. The predominantly observed resistance was to cephalothin (42.1%), tetracycline (20%) and ampicillin (15.8%) among the isolates from diarrheic cats while in the healthy the tetracycline resistance was most frequent (30.5%), allowed by cotrimoxazol (17.9%) and ampicillin (20.0%). Cats with UTI showed greater resistance to ampicillin (46.7%), cephalothin (13.3%) and nalidixic acid (13.3%). Multidrug resistance was found in 8.4%, 17.9% and 33.3% of strains isolated from diarrheic healthy and with symptoms of UTI cats, respectively. The phenotype of resistance extended to beta-lactams (ESBL) was not... (Summary complete electronic access click below) / Mestre

Made available in DSpace on 2014-12-17T15:30:48Z (GMT). No. of bitstreams: 1 LizaBV.pdf: 651863 bytes, checksum: 861130b51ad28ee890a75755594ddae3 (MD5) Previous issue date: 2006-05-19 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior / The purpose of this study was evaluate the effectiveness of the chitosan at 0.4 with high molecular weight and high deacetylation degree mouthrinse over the total decrease of the streptococci, Streptococcus mutans, lactobaci/li and over the perceptible bacterial film and gingival bleeding indices. For that, a total of 68 healthy students between 11 and 13 years old, not allergic to crustacean and not users of antibiotics or antimicrobial agent for the last three months or during the treatment, was selected. From those, thirty two individuaIs used the mouthrinse test, and thirty six, the control one. The participants rinsed 10 mL of the solutions twice a day, one during the moming (which was supervised), and another one during the aftemoon (which was not supervised), for fifteen days. The saliva collect for the microbiological analysis, as well as the perceptible bacterial film and gingival bleeding indices check, were made before the use ofthe mouthrinses (base line), immediately after the last mouthrinse on the day (zero time) and fifteen days after (fifteen time). These data were collected at school and the saliva was carried inside the ice to the laboratory. The samples were diluted, and 0.1 mL ofthe 10 -1 dilution was seeded in Rogosa SL agar, for further analysis of the total of lactobaci/lus~ 0.1 mL of the 10-4 dilution in Mitis Salivarius with bacitracin, for S. mutans analysis; and 0.1 mL of the 10-6 dilution in Mitis Salivarius for the analysis ofthe total of streptococcus. The Rogosa SL agar plates were incubated in aerobic at 37?C for 72 hours and the MSB and the MS were incubated in anaerobic in Gaspak@ jars at 37?C for 48 hours for further count ofColonies Former Units (CFUs). The assay was made in duplicate for each bacterial group analyzed. The number of CFUs transformed in LOGlO was analyzed according to the following tests: ANOV A, t of Paired and Not Paired Student, Friedman, Man-Whitney and square-qui test. On the base line, alI the variables analyzed were similar on both tested groups. On both groups, for the total of streptococcus there was no significant difference along the time and for S. mutans there was a statistic significant increase of the CFUs from the base line to the zero time. For the total of lactobaccilus there was no significant difference on the test group along the time, and on the control there was a significant increase ofthe CFUs ITom the base line to the zero time. For both groups, there was significant decrease ofthe perceptible bacterial film index along the time, and that can be explained by the mechanic effect of the mouthrinse over the bacterial film and by the participation of the students on the research which could have motivated him to a better toothbrushing (Hawthome effect). The gingival bleeding index also showed a decrease along the time, even though it was not significant. Therefore, the conclusion of this study was that the chitosan at 0.4 % mouthrinse was not effective on the CFUs reduction of the three bacterial groups analyzed, as well as on the reduction of the perceptible bacterial film and gingival bleeding indices / O objetivo deste estudo foi avaliar a efic?cia do bochecho de quitosana a 0,4% com alto peso molecular e alto grau de desacetiliza??o sobre a redu??o do total de estreptococcus, Streptococcus mutans, total de lactobacilos e sobre os ?ndices de placa vis?vel e sangramento gengival. Para tanto, foram selecionados 68 estudantes saud?veis, com idade entre 11 e 13 anos, n?o al?rgicos a crust?ceos e que n?o tivessem usado antibi?tico ou antimicrobiano nos ?ltimos tr?s meses ou durante o tratamento. Trinta e dois indiv?duos utilizaram o bochecho teste e trinta e seis o controle. Os participantes bochecho 10 ML das solu??es duas vezes ao dia, um pela manh? (supervisionado) e outro ? tarde (n?o supervisionado, durante quinza dias. A coleta de saliva para an?lise microbiol?gica, bem como a aferi??o dos ?ndices de placa vis?vel e de sangramento gengival, deu-se antes do uso dos bochechos (linha base),no dia imediatamento ap?s o ?ltimo bochecho (tempo zero) e quinze dias ap?s (tempo quinze). Esses dados foram coletados na escola e a saliva transportada em gelo at? o laborat?rio. As amostras de saliva foram diluidas e 0,1ML da dilui??o 10 elevado a menos 1 foi semeada em Rogosa SL ?gar para a posterior an?lise do total de lactobacilos; 0,1mL da dilui??o 10 elevado a menos 4 em Mitis Salivarus com bacitracina, para an?lise de S mutans, e 0,1mL da dilui??o 10 elevado a menos 6 em Mitis Salivarius para an?lise do total de estreptococous. As placas de Rogosa SL ?gar foram incubadas em aerobiose a 37 grau cent?grado por 72 horas e as de MSB e MS foram incubadas em anaeribiose em jarras Gaspak a 337 grau cent?grado, por 48 horas, para posterior contagem das unidades formadoras de col?nias (UFCs). O ensaio foi feito em duplicadta para cada grupo bacteriano analisado. O n?mero de UFCs transformados em LOG10 foi analisado mediante os seguintes testes: ANOVA, t de Student emparelhado e n?o emparelhado, Friedman, Man-Whitney e teste do qui-quadrado. Na linha base, todas as vari?veis analisadas no estudo foram semelhantes nos dois grupos testados. Em ambos os grupos, para o total de estreptococcus n?o houve diferen?a significativa ao longo do tempo; para o S. mutans, houve aumento estatisticamente significativo das UFCs da linha base para o T0. Para o total de lactobacilos, n?o houve diferen?a no grupo teste ao longo do tempo e, no controle, houve aumento significativo das UFCs da linha base para o T0. Em ambos os grupos, houve diminui??o significativa do IPV ao longo do tempo. O ISG tamb?m apresentou redu??o ao longo do tempo, por?m n?o foi significativa. Portanto, este estudo concluiu que o bochecho de quitosana a 0,4% n?o foi eficaz na redu??o das UFCs dos tr?s grupos bacterianos analisados, assim como, na redu??o do IPV e ISG

Nous avons synthétisé des composés d'étain avec des acides undécylénique, ricinoléique et caprylique. Ils ont une activité importante contre certaines souches de microrganismes, puisque ils agissent pour certains d’entre eux à des concentrations nanomolaires. Staphylococcus aureus semble être 4000 fois plus sensible à leur toxicité que les cellules de mammifères. Nous avons obtenu des composés du ruthénium qui présentent cytotoxicité contre des cellules cancéreuses suivant un mécanisme d'action différent de ceux observés pour le Cisplatine ou d'autres composés de Ru, grâce à leur grande stabilité dans les réactions de substitution. Enfin, pendant la vectorisation des composés dérivés du Ru avec une Affitine nous avons pu acquérir des connaissances importantes sur un éventuel mécanisme d'action de ce type de molécules dont le potentiel redox très abaissé par rapport aux composés correspondants pourrait être responsable de la polymérisation de protéines cibles par transfert d’électron. / Related to antimicrobial research, we synthesized tin compounds derived from undecylenic, ricinoleic and caprylic acids and we found that they show very high activity against some strains of bacteria and yeast, even in nM range, being up to four thousand times more potent against Staphylococcus aureus than against mammalian cells. For ruthenium compounds, in turn, we have confirmed that the mode of action of some compounds that were synthesized recently is undoubtedly different from Cisplatin or other ruthenium compounds, because of their high stability toward substitution reactions. Finally, during the vectorization of compounds derived from Ru with Affitin we have gained important knowledge about a possible mechanism of action of this type of molecule: it could indeed be possible that these compounds which have a very reduced redox potential compared to corresponding compounds can cause polymerization of proteins by electron transfer.

O objetivo deste trabalho foi avaliar o potencial antifúngico contra o fungo Aspergillus flavus, dos extratos de folhas de Eucalyptus staigeriana F. Muell., preparados a partir de folhas frescas, liofilizadas e secas ao ambiente, sob diferentes tempos de extração e por diferentes solventes extratores, tais como metanol, etanol e água a temperatura ambiente e água a 60ºC. Para mensurar o potencial antifúngico foi utilizada a técnica de poisoned food em meio BDA e o crescimento radial fúngico foi avaliado por seis dias. O percentual de inibição foi avaliado comparando-se as medidas do diâmetro radial de crescimento fúngico dos extratos com as placas controle contendo apenas os solventes. Como controle positivo foi utilizado o óleo essencial de E. staigeriana. Os extratos metanólicos apresentaram o melhor potencial antifúngico, seguido pelos extratos etanólicos e aquosos. A utilização das folhas frescas mostrou-se a melhor forma de preparação e não houve diferença significativa entre os tempos de extração 1h e 24h, indicando como processamento mais viável a extração em 1h. A Concentração Inibitória Mínima (MIC) foi mensurada para o extrato de melhor desempenho pela técnica de micropoços, aonde o crescimento fúngico foi monitorado por fluorescência derivada da reação da esterase fúngica com o diacetado de fluorescina. E o extrato que obteve o melhor resultado foi o extrato metanólico, com 1h de extração, a partir de folhas liofilizadas de E. staigeriana, e sua MIC foi de 26,75 L/mL, enquanto a do seu óleo essencial foi de 12,5 L/mL, demonstrando a eficiência relativa da extração com solventes extratores e sua praticidade e operacionalidade, quando se comparam com a extração de óleos essenciais. / This study aimed to evaluate the antifungal potential of Eucalyptus staigeriana F. Muell. leaf extracts against Aspergillus flavus. The extracts were prepared using fresh, lyophilized, and air-dried leaves, different extraction times, and different solvents, such as methanol, ethanol, water at room temperature, and water at 60ºC. To measure the antifungal potential, the poisoned food technique was used in PDA medium, and the radial growth of the fungus was evaluated for six days. The percentage of inhibition was assessed by comparing the measurements of the radial growth diameter of the fungus in the extracts with the control plates containing only the solvents. The essential oil of E. staigeriana was used as a positive control. The methanolic extracts presented the best antifungal potential, followed by the ethanolic and aqueous extracts. The use of fresh leaves was the best type of preparation and no statistically significant difference between 1-h and 24-h solvent extraction was found, indicating the 1-h extraction process as the most feasible. The extract presenting the best performance using the microwell technique had the minimum inhibitory concentration (MIC) measured, and the fungal growth was monitored by fluorescence derived from the fungal esterase reaction with fluorescein diacetate. The extract that achieved the best result the methanolic extract, with 1-h extraction from lyophilized leaves of E. staigeriana, and the MIC was 26.75 L/mL, while the essential oil was 12.5 L/mL, demonstrating the relative efficiency of the solvent extraction and its practicality and easy implementation when compared with the extraction of essential oils.

Actuellement, le traitement des pathologies infectieuses chez les bovins et les animaux de compagnie est menacé par l’accroissement de l’antibiorésistance et des bactéries multirésistantes. Il est donc primordial pour les entreprises pharmaceutiques vétérinaires de développer de nouvelles gammes d’agents antibactériens spécifiques au domaine animale. Dans ce contexte, il a été montré que certains polyaminostérols naturels tels que la squalamine possèdent un fort potentiel antimicrobien. Ainsi, l’objectif de ce travail de thèse est de répondre à la problématique présentée par la société Virbac dans le traitement des mammites (bovins) et des otites/pyodermites (chien) par le développement d’une nouvelle classe de dérivés polyaminostéroïdiens synthétiques à large spectre antimicrobien. Pour cela, nous avons constitué une chimiothèque de composés originaux préparés à partir de différents acides biliaires selon des voies de synthèse inédites. Ces composés ont été évalués in vitro pour leur cytotoxicité et leurs activités antibactériennes contre diverses bactéries à Gram positif et à Gram négatif et nous avons pu établir la preuve de concept in vitro de leur potentiel thérapeutique en tant qu’agents antibactériens ou adjuvants d’antibiotiques. De plus, nous avons montré que l’un de ces nouveaux dérivés, la claramine A1, agit sur l’intégrité physique des membranes bactériennes et sur les performances d'efflux des pompes AcrAB-TolC. Ainsi, il apparaît finalement que ces dérivés polyaminostéroïdiens au mode d’action non conventionnel pourraient constituer une nouvelle classe d’agents antibactériens pour un usage en tant que substituts d’antibiotiques en médecine vétérinaire. / Currently, the treatment of infectious pathologies in cattle and pets is threatened by the growing antimicrobial resistance and the development of multidrug-resistant bacteria. Thus it is necessary for the veterinary pharmaceutical firms to develop new lines of antibacterial agents. In this context, some natural polyaminosterols such as squalamine have gained interest due to their potent antimicrobial activities. Thus the aim of this PhD work is to provide an answer in the treatment of mastitis (cattle) and otitis/pyoderma (dog) by the development of a new class of synthetic polyaminosterols with a broad spectrum of antibacterial activity. In this purpose, a chemical library of original compounds has been prepared starting from various bile acids by using unprecedented synthesis procedures. These compounds were evaluated for their in vitro cytotoxicity on CHO cells as well as their antibacterial activities against Gram-positive and Gram-negative bacteria and we have establish the in vitro proof of concept of the therapeutic potential of this family of molecules as antibacterial agent or antibiotic adjuvant. Additional investigations were then conducted on one of these novel derivatives namely claramine A1 to deepen knowledge of its mechanism of action and showed that claramine A1 acts on the physical integrity of bacterial membranes and the efflux performance of AcrAB-TolC pumps. Based on the results of claramine A1, it finally appears that these new polyaminosterol derivatives possessing a non-classical mode of action pertain to a new class of antibacterial agents and could constitute a substitute for traditional antibiotics in veterinary medicine.